“A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: A tertiary care centre experience
Clinical Endocrinology · 2023
DOI: 10.1111/cen.14934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2023. Verfasst von Shani A D Mathara Diddhenipothage und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill hospital, Oxford University Hospitals, NHS Trust, Oxford, UK. Hauptthemen laut MEDLINE: Hydrocortisone, Adrenal Insufficiency. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Objective
Increasing referrals to Endocrinology with nonspecific symptoms of suspected adrenal insufficiency (AI) has increased use of the short‐synacthen test (SST). Prevailing resource and safety concerns emphasise importance of patient selection criterion to optimise SST use. This study aimed to (1) document the adverse event profile of the SST (2) identify any pretest predictors of SST outcome. Design, Patients and Measurements Retrospective data analysis of all patients referred for SST in Oxford from 2017 to 2021. Pretest clinical variables (age, sex, BMI, blood pressure and electrolytes), symptoms (fatigue, dizziness, weight loss) and pretest morning cortisol were included in the statistical model with the aim of identifying any variables that could predict SST outcome in Group 1 primary AI, Group 2 central AI and Group 3 glucocorticoid induced AI. Symptoms and signs during and post SST were also noted with the aim of describing adverse effects to synacthen across a large cohort.
Results
A total 1480 SSTs (Males:38%, age 52 [39−66] years) were performed: 505 (34.1%) in Group 1, 838 (57%) in Group 2, and 137 (9.3%) in Group 3. Adverse‐effects were recorded in 1.8% of tests, including one episode of anaphylaxis. Pretest morning‐cortisol was the only predictor for an “SST pass” (whole cohort: B = 0.015, p < 0.001, Group 1: B = 0.018, p < .001; Group 2: B = 0.010, p < 0.012; Group 3: B = 0.018, p =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill hospital, Oxford University Hospitals, NHS Trust, Oxford, UK.
- Oxford Centre for Diabetes, Endocrinology, and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
ORCID-Profile: Shani A D Mathara Diddhenipothage
Förderung
- Medical Research Council
Zitieren
APA
Mathara Diddhenipothage, S. A. D., Beck, K. J., Loo, H., Amiyangoda, G. K., Pofi, R., Tomlinson, J. W., & Pal, A. (2023). “A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: A tertiary care centre experience. Clinical Endocrinology. https://doi.org/10.1111/cen.14934
Vancouver
Mathara Diddhenipothage SAD, Beck KJ, Loo H, Amiyangoda GK, Pofi R, Tomlinson JW, et al. “A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: A tertiary care centre experience. Clinical Endocrinology. 2023. doi:10.1111/cen.14934
BibTeX
@article{MatharaDiddhenipothage2023,
author = {Mathara Diddhenipothage, Shani A D and Beck, Katharina J and Loo, Helen and Amiyangoda, Gayana K and Pofi, Riccardo and Tomlinson, Jeremy W and Pal, Aparna},
title = {“A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: A tertiary care centre experience},
journal = {Clinical Endocrinology},
year = {2023},
doi = {10.1111/cen.14934}
}
EUVIMED